VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q38642741  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241221010714.0
008     241221nneanz||abbn n and d
035 ‎‡a  (WKP)Q38642741‏
024 ‎‡a  0000-0003-2953-3284‏ ‎‡2  orcid‏
024 ‎‡a  6602825121‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q38642741‏
100 0 ‎‡a  Diego Arango‏ ‎‡9  ast‏ ‎‡9  it‏ ‎‡9  sl‏ ‎‡9  es‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  Diego Arango del Corro‏ ‎‡9  fr‏ ‎‡9  pt‏ ‎‡9  ca‏ ‎‡9  de‏ ‎‡9  pt-br‏
400 0 ‎‡a  Diego Arango‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Diego Arango del Corro‏ ‎‡c  ikertzailea‏ ‎‡9  eu‏
400 0 ‎‡a  Diego Arango‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's 7q deletion mapping and expression profiling in uterine fibroids.‏
670 ‎‡a  Author's A gene expression profile that defines colon cell maturation in vitro.‏
670 ‎‡a  Author's A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition‏
670 ‎‡a  Author's AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells.‏
670 ‎‡a  Author's An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor‏
670 ‎‡a  Author's An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression‏
670 ‎‡a  Author's Apigenin protects endothelial cells from lipopolysaccharide‏
670 ‎‡a  Author's Apigenin protects endothelial cells from lipopolysaccharide (LPS)-induced inflammation by decreasing caspase-3 activation and modulating mitochondrial function‏
670 ‎‡a  Author's Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.‏
670 ‎‡a  Author's Application of gene expression profiling to colon cell maturation, transformation and chemoprevention.‏
670 ‎‡a  Author's Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment.‏
670 ‎‡a  Author's BB-10010, an analog of macrophage inflammatory protein-1alpha, protects murine small intestine against radiation‏
670 ‎‡a  Author's BB-10010, an analogue of macrophage inflammatory protein-1 alpha, reduces proliferation in murine small-intestinal crypts‏
670 ‎‡a  Author's Brush border myosin Ia has tumor suppressor activity in the intestine.‏
670 ‎‡a  Author's Brush border myosin Ia inactivation in gastric but not endometrial tumors.‏
670 ‎‡a  Author's c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis.‏
670 ‎‡a  Author's c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.‏
670 ‎‡a  Author's Cancer stem cells and personalized cancer nanomedicine.‏
670 ‎‡a  Author's Candidate driver genes in microsatellite-unstable colorectal cancer‏
670 ‎‡a  Author's Clinical response to fluorouracil and p53.‏
670 ‎‡a  Author's Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer‏
670 ‎‡a  Author's Customizing chemotherapy for colon cancer: the potential of gene expression profiling.‏
670 ‎‡a  Author's Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine.‏
670 ‎‡a  Author's Diagnostic ultrasound induces change within numbers of cryptal mitotic and apoptotic cells in small intestine‏
670 ‎‡a  Author's Distinct expression profile in fumarate-hydratase-deficient uterine fibroids‏
670 ‎‡a  Author's Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status‏
670 ‎‡a  Author's Dose-effect relationship of BB-10010/MIP-1 alpha on proliferation in murine small intestinal epithelium: single and double administration protocols‏
670 ‎‡a  Author's Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.‏
670 ‎‡a  Author's DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.‏
670 ‎‡a  Author's Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells‏
670 ‎‡a  Author's EPH receptors in cancer.‏
670 ‎‡a  Author's EPHB4 and survival of colorectal cancer patients.‏
670 ‎‡a  Author's Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer.‏
670 ‎‡a  Author's Extracellular vesicles secreted by triple‐negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs‏
670 ‎‡a  Author's Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells‏
670 ‎‡a  Author's Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.‏
670 ‎‡a  Author's Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer‏
670 ‎‡a  Author's Gene expression signatures for colorectal cancer microsatellite status and HNPCC.‏
670 ‎‡a  Author's Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families‏
670 ‎‡a  Author's HDAC4 promotes growth of colon cancer cells via repression of p21.‏
670 ‎‡a  Author's High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability.‏
670 ‎‡a  Author's Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment.‏
670 ‎‡a  Author's Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer‏
670 ‎‡a  Author's Human SMC2 protein, a core subunit of human condensin complex, is a novel transcriptional target of the WNT signaling pathway and a new therapeutic target.‏
670 ‎‡a  Author's Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells‏
670 ‎‡a  Author's Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.‏
670 ‎‡a  Author's Loss of the EPH receptor B6 contributes to colorectal cancer metastasis‏
670 ‎‡a  Author's Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.‏
670 ‎‡a  Author's Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer‏
670 ‎‡a  Author's Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer‏
670 ‎‡a  Author's Microarray analysis in the clinical management of cancer‏
670 ‎‡a  Author's Modeling tumor predisposing FH mutations in yeast: effects on fumarase activity, growth phenotype and gene expression profile.‏
670 ‎‡a  Author's Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.‏
670 ‎‡a  Author's Mutations in the circadian gene CLOCK in colorectal cancer‏
670 ‎‡a  Author's Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers‏
670 ‎‡a  Author's Myo5b knockout mice as a model of microvillus inclusion disease.‏
670 ‎‡a  Author's Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT‏
670 ‎‡a  Author's Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer‏
670 ‎‡a  Author's Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention.‏
670 ‎‡a  Author's Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression‏
670 ‎‡a  Author's PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab‏
670 ‎‡a  Author's PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.‏
670 ‎‡a  Author's RHOA inactivation enhances Wnt signalling and promotes colorectal cancer.‏
670 ‎‡a  Author's Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis‏
670 ‎‡a  Author's Short chain fatty acids and colon cancer‏
670 ‎‡a  Author's Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth.‏
670 ‎‡a  Author's SMAD4 as a Prognostic Marker in Colorectal Cancer‏
670 ‎‡a  Author's SMAD4 levels and response to 5-fluorouracil in colorectal cancer‏
670 ‎‡a  Author's The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase‏
670 ‎‡a  Author's The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.‏
670 ‎‡a  Author's The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.‏
670 ‎‡a  Author's TR3/Nur77 in colon cancer cell apoptosis.‏
670 ‎‡a  Author's Transforming pathways unleashed by a HDAC2 mutation in human cancer.‏
670 ‎‡a  Author's Tumor necrosis factor-alpha related gene response to Epothilone B in ovarian cancer‏
670 ‎‡a  Author's Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells‏
670 ‎‡a  Author's Unregulated smooth-muscle myosin in human intestinal neoplasia‏
670 ‎‡a  Author's Villin expression is frequently lost in poorly differentiated colon cancer.‏
909 ‎‡a  (scopus) 6602825121‏ ‎‡9  1‏
909 ‎‡a  (orcid) 0000000329533284‏ ‎‡9  1‏
919 ‎‡a  mechanismsofinactivationofthetumoursuppressorgenerhoaincolorectalcancer‏ ‎‡A  Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer‏ ‎‡9  1‏
919 ‎‡a  microarrayanalysisintheclinicalmanagementofcancer‏ ‎‡A  Microarray analysis in the clinical management of cancer‏ ‎‡9  1‏
919 ‎‡a  investigationoftheroleoftyrosinekinasereceptorepha3incolorectalcancer‏ ‎‡A  Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.‏ ‎‡9  1‏
919 ‎‡a  modelingtumorpredisposingfhmutationsinyeasteffectsonfumaraseactivitygrowthphenotypeandgeneexpressionprofile‏ ‎‡A  Modeling tumor predisposing FH mutations in yeast: effects on fumarase activity, growth phenotype and gene expression profile.‏ ‎‡9  1‏
919 ‎‡a  intracellulardeliveryofantismc2antibodiesagainstcancerstemcells‏ ‎‡A  Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells‏ ‎‡9  1‏
919 ‎‡a  molecularmechanismsofactionandpredictionofresponsetooxaliplatinincolorectalcancercells‏ ‎‡A  Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.‏ ‎‡9  1‏
919 ‎‡a  mutationsinthecircadiangeneclockincolorectalcancer‏ ‎‡A  Mutations in the circadian gene CLOCK in colorectal cancer‏ ‎‡9  1‏
919 ‎‡a  mutationsin2shortnoncodingmononucleotiderepeatsinmostmicrosatelliteunstablecolorectalcancers‏ ‎‡A  Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers‏ ‎‡9  1‏
919 ‎‡a  humansmc2proteinacoresubunitofhumancondensincomplexisanoveltranscriptionaltargetofthewntsignalingpathwayandanewtherapeutictarget‏ ‎‡A  Human SMC2 protein, a core subunit of human condensin complex, is a novel transcriptional target of the WNT signaling pathway and a new therapeutic target.‏ ‎‡9  1‏
919 ‎‡a  histonedeacetylase3hdac3andotherclass1hdacsregulatecoloncellmaturationandp21expressionandarederegulatedinhumancoloncancer‏ ‎‡A  Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer‏ ‎‡9  1‏
919 ‎‡a  myo5bknockoutmiceasamodelofmicrovillusinclusiondisease‏ ‎‡A  Myo5b knockout mice as a model of microvillus inclusion disease.‏ ‎‡9  1‏
919 ‎‡a  highlyexpressedgenesinrapidlyproliferatingtumorcellsasnewtargetsforcolorectalcancertreatment‏ ‎‡A  Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment.‏ ‎‡9  1‏
919 ‎‡a  highephb2mutationrateingastricbutnotendometrialtumorswithmicrosatelliteinstability‏ ‎‡A  High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability.‏ ‎‡9  1‏
919 ‎‡a  na+monocarboxylatetransportsmctproteinexpressioncorrelateswithsurvivalincoloncancermolecularcharacterizationofsmct‏ ‎‡A  Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT‏ ‎‡9  1‏
919 ‎‡a  nanotechnologyisanimportantstrategyforcombinationalinnovativechemoimmunotherapiesagainstcolorectalcancer‏ ‎‡A  Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer‏ ‎‡9  1‏
919 ‎‡a  noveldetectionanddifferentialutilizationofa100myctranscriptionalblockincoloncancerchemoprevention‏ ‎‡A  Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention.‏ ‎‡9  1‏
919 ‎‡a  oncogenickirasinhibitstheexpressionofinterferonresponsivegenesthroughinhibitionofstat1andstat2expression‏ ‎‡A  Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression‏ ‎‡9  1‏
919 ‎‡a  pik3camutationptenexpressionstatuspredictsresponseofcoloncancercellstotheepidermalgrowthfactorreceptorinhibitorcetuximab‏ ‎‡A  PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab‏ ‎‡9  1‏
919 ‎‡a  hdac4promotesgrowthofcoloncancercellsviarepressionofp21‏ ‎‡A  HDAC4 promotes growth of colon cancer cells via repression of p21.‏ ‎‡9  1‏
919 ‎‡a  germlinehypermethylationoftheapcpromoterisnotafrequentcauseoffamilialadenomatouspolyposisinapcmutyhmutationnegativefamilies‏ ‎‡A  Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families‏ ‎‡9  1‏
919 ‎‡a  ptprdishomozygouslydeletedandepigeneticallydownregulatedinhumanhepatocellularcarcinomas‏ ‎‡A  PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.‏ ‎‡9  1‏
919 ‎‡a  geneexpressionsignaturesforcolorectalcancermicrosatellitestatusandhnpcc‏ ‎‡A  Gene expression signatures for colorectal cancer microsatellite status and HNPCC.‏ ‎‡9  1‏
919 ‎‡a  geneexpressionprofilingpredictsrecurrenceindukes100colorectalcancer‏ ‎‡A  Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer‏ ‎‡9  1‏
919 ‎‡a  geneexpressionprofilingbasedpredictionofresponseofcoloncarcinomacellsto5fluorouracilandcamptothecin‏ ‎‡A  Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.‏ ‎‡9  1‏
919 ‎‡a  fluorescentcscmodelsevidencethattargetednanomedicinesimprovetreatmentsensitivityofbreastandcoloncancerstemcells‏ ‎‡A  Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells‏ ‎‡9  1‏
919 ‎‡a  extracellularvesiclessecretedbytriplenegativebreastcancerstemcellstriggerpremetastaticnicheremodelingandmetastaticgrowthinthelungs‏ ‎‡A  Extracellular vesicles secreted by triple‐negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs‏ ‎‡9  1‏
919 ‎‡a  expressionofseleniumbindingprotein1characterizesintestinalcellmaturationandpredictssurvivalforpatientswithcolorectalcancer‏ ‎‡A  Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer.‏ ‎‡9  1‏
919 ‎‡a  rhoainactivationenhanceswntsignallingandpromotescolorectalcancer‏ ‎‡A  RHOA inactivation enhances Wnt signalling and promotes colorectal cancer.‏ ‎‡9  1‏
919 ‎‡a  serratedcarcinomasformasubclassofcolorectalcancerwithdistinctmolecularbasis‏ ‎‡A  Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis‏ ‎‡9  1‏
919 ‎‡a  shortchainfattyacidsandcoloncancer‏ ‎‡A  Short chain fatty acids and colon cancer‏ ‎‡9  1‏
919 ‎‡a  silencingofadaptorproteinsh3bp2reduceskitpdgfrareceptorsexpressionandimpairsgastrointestinalstromaltumorsgrowth‏ ‎‡A  Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth.‏ ‎‡9  1‏
919 ‎‡a  smad4asaprognosticmarkerincolorectalcancer‏ ‎‡A  SMAD4 as a Prognostic Marker in Colorectal Cancer‏ ‎‡9  1‏
919 ‎‡a  ephb4andsurvivalofcolorectalcancerpatients‏ ‎‡A  EPHB4 and survival of colorectal cancer patients.‏ ‎‡9  1‏
919 ‎‡a  ephreceptorsincancer‏ ‎‡A  EPH receptors in cancer.‏ ‎‡9  1‏
919 ‎‡a  dynamismsensitivityandconsequencesofmesenchymalandstemlikephenotypeofcancercells‏ ‎‡A  Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells‏ ‎‡9  1‏
919 ‎‡a  dusp5ismethylatedincimphighcolorectalcancerbutisnotamajorregulatorofintestinalcellproliferationandtumorigenesis‏ ‎‡A  DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.‏ ‎‡9  1‏
919 ‎‡a  dualtargetingofbromodomainandextraterminaldomainproteinsandwntormapksignalinginhibits100mycexpressionandproliferationofcolorectalcancercells‏ ‎‡A  Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.‏ ‎‡9  1‏
919 ‎‡a  doseeffectrelationshipofbb10010mip1alphaonproliferationinmurinesmallintestinalepitheliumsingleanddoubleadministrationprotocols‏ ‎‡A  Dose-effect relationship of BB-10010/MIP-1 alpha on proliferation in murine small intestinal epithelium: single and double administration protocols‏ ‎‡9  1‏
919 ‎‡a  distinctpatternsofkrasmutationsincolorectalcarcinomasaccordingtogermlinemismatchrepairdefectsandhmlh1methylationstatus‏ ‎‡A  Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status‏ ‎‡9  1‏
919 ‎‡a  distinctexpressionprofileinfumaratehydratasedeficientuterinefibroids‏ ‎‡A  Distinct expression profile in fumarate-hydratase-deficient uterine fibroids‏ ‎‡9  1‏
919 ‎‡a  smad4levelsandresponseto5fluorouracilincolorectalcancer‏ ‎‡A  SMAD4 levels and response to 5-fluorouracil in colorectal cancer‏ ‎‡9  1‏
919 ‎‡a  intestinalepithelialcelldifferentiationmarkerintestinalalkalinephosphatase‏ ‎‡A  The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase‏ ‎‡9  1‏
919 ‎‡a  intestinalepithelialcelldifferentiationmarkerintestinalalkalinephosphatasealpiisselectivelyinducedbyhistonedeacetylaseinhibitorshdaciincoloncancercellsinakruppellikefactor5klf5dependentmanner‏ ‎‡A  The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.‏ ‎‡9  1‏
919 ‎‡a  receptortyrosinekinaseephb4hastumorsuppressoractivitiesinintestinaltumorigenesis‏ ‎‡A  The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.‏ ‎‡9  1‏
919 ‎‡a  tr3nur77incoloncancercellapoptosis‏ ‎‡A  TR3/Nur77 in colon cancer cell apoptosis.‏ ‎‡9  1‏
919 ‎‡a  transformingpathwaysunleashedbyahdac2mutationinhumancancer‏ ‎‡A  Transforming pathways unleashed by a HDAC2 mutation in human cancer.‏ ‎‡9  1‏
919 ‎‡a  tumornecrosisfactoralpharelatedgeneresponsetoepothilonebinovariancancer‏ ‎‡A  Tumor necrosis factor-alpha related gene response to Epothilone B in ovarian cancer‏ ‎‡9  1‏
919 ‎‡a  tumourselectionadvantageofnondominantnegativep53mutationsinhomozygoticmdm2snp309colorectalcancercells‏ ‎‡A  Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells‏ ‎‡9  1‏
919 ‎‡a  unregulatedsmoothmusclemyosininhumanintestinalneoplasia‏ ‎‡A  Unregulated smooth-muscle myosin in human intestinal neoplasia‏ ‎‡9  1‏
919 ‎‡a  villinexpressionisfrequentlylostinpoorlydifferentiatedcoloncancer‏ ‎‡A  Villin expression is frequently lost in poorly differentiated colon cancer.‏ ‎‡9  1‏
919 ‎‡a  metastasisassociatedgeneexpressionchangespredictpooroutcomesinpatientswithdukesstageband100colorectalcancer‏ ‎‡A  Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer‏ ‎‡9  1‏
919 ‎‡a  diagnosticultrasoundinduceschangewithinnumbersofcryptalmitoticandapoptoticcellsinsmallintestine‏ ‎‡A  Diagnostic ultrasound induces change within numbers of cryptal mitotic and apoptotic cells in small intestine‏ ‎‡9  1‏
919 ‎‡a  decreasein100mycactivityenhancescancercellsensitivitytovinblastine‏ ‎‡A  Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine.‏ ‎‡9  1‏
919 ‎‡a  customizingchemotherapyforcoloncancerthepotentialofgeneexpressionprofiling‏ ‎‡A  Customizing chemotherapy for colon cancer: the potential of gene expression profiling.‏ ‎‡9  1‏
919 ‎‡a  colorectalcancercelllinesarerepresentativemodelsofthemainmolecularsubtypesofprimarycancer‏ ‎‡A  Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer‏ ‎‡9  1‏
919 ‎‡a  clinicalresponsetofluorouracilandp53‏ ‎‡A  Clinical response to fluorouracil and p53.‏ ‎‡9  1‏
919 ‎‡a  candidatedrivergenesinmicrosatelliteunstablecolorectalcancer‏ ‎‡A  Candidate driver genes in microsatellite-unstable colorectal cancer‏ ‎‡9  1‏
919 ‎‡a  cancerstemcellsandpersonalizedcancernanomedicine‏ ‎‡A  Cancer stem cells and personalized cancer nanomedicine.‏ ‎‡9  1‏
919 ‎‡a  100mycp53interactiondeterminessensitivityofhumancoloncarcinomacellsto5fluorouracilinvitroandinvivo‏ ‎‡A  c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.‏ ‎‡9  1‏
919 ‎‡a  100mycoverexpressionsensitisescoloncancercellstocamptothecininducedapoptosis‏ ‎‡A  c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis.‏ ‎‡9  1‏
919 ‎‡a  brushbordermyosiniainactivationingastricbutnotendometrialtumors‏ ‎‡A  Brush border myosin Ia inactivation in gastric but not endometrial tumors.‏ ‎‡9  1‏
919 ‎‡a  brushbordermyosiniahastumorsuppressoractivityintheintestine‏ ‎‡A  Brush border myosin Ia has tumor suppressor activity in the intestine.‏ ‎‡9  1‏
919 ‎‡a  bb10010ananalogueofmacrophageinflammatoryprotein1alphareducesproliferationinmurinesmallintestinalcrypts‏ ‎‡A  BB-10010, an analogue of macrophage inflammatory protein-1 alpha, reduces proliferation in murine small-intestinal crypts‏ ‎‡9  1‏
919 ‎‡a  bb10010ananalogofmacrophageinflammatoryprotein1alphaprotectsmurinesmallintestineagainstradiation‏ ‎‡A  BB-10010, an analog of macrophage inflammatory protein-1alpha, protects murine small intestine against radiation‏ ‎‡9  1‏
919 ‎‡a  aprataxintumorlevelspredictresponseofcolorectalcancerpatientstoirinotecanbasedtreatment‏ ‎‡A  Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment.‏ ‎‡9  1‏
919 ‎‡a  applicationofgeneexpressionprofilingtocoloncellmaturationtransformationandchemoprevention‏ ‎‡A  Application of gene expression profiling to colon cell maturation, transformation and chemoprevention.‏ ‎‡9  1‏
919 ‎‡a  apoptoticsensitivityofcoloncancercellstohistonedeacetylaseinhibitorsismediatedbyansp1sp3activatedtranscriptionalprograminvolvingimmediateearlygeneinduction‏ ‎‡A  Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.‏ ‎‡9  1‏
919 ‎‡a  apigeninprotectsendothelialcellsfromlipopolysaccharidelpsinducedinflammationbydecreasingcaspase3activationandmodulatingmitochondrialfunction‏ ‎‡A  Apigenin protects endothelial cells from lipopolysaccharide (LPS)-induced inflammation by decreasing caspase-3 activation and modulating mitochondrial function‏ ‎‡9  1‏
919 ‎‡a  apigeninprotectsendothelialcellsfromlipopolysaccharide‏ ‎‡A  Apigenin protects endothelial cells from lipopolysaccharide‏ ‎‡9  1‏
919 ‎‡a  a13repeatwithinthe3untranslatedregionofepidermalgrowthfactorreceptoregfrisfrequentlymutatedinmicrosatelliteinstabilitycoloncancersandisassociatedwithincreasedegfrexpression‏ ‎‡A  An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression‏ ‎‡9  1‏
919 ‎‡a  a13repeatwithinthe3untranslatedregionofepidermalgrowthfactorreceptor‏ ‎‡A  An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor‏ ‎‡9  1‏
919 ‎‡a  akt2sirnadeliverywithamphiphilicbasedpolymericmicellesshowefficacyagainstcancerstemcells‏ ‎‡A  AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells.‏ ‎‡9  1‏
919 ‎‡a  truncatingmutationofhdac2inhumancancersconfersresistancetohistonedeacetylaseinhibition‏ ‎‡A  A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition‏ ‎‡9  1‏
919 ‎‡a  geneexpressionprofilethatdefinescoloncellmaturationinvitro‏ ‎‡A  A gene expression profile that defines colon cell maturation in vitro.‏ ‎‡9  1‏
919 ‎‡a  7qdeletionmappingandexpressionprofilinginuterinefibroids‏ ‎‡A  7q deletion mapping and expression profiling in uterine fibroids.‏ ‎‡9  1‏
919 ‎‡a  mechanismsofinactivationofthereceptortyrosinekinaseephb2incolorectaltumors‏ ‎‡A  Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.‏ ‎‡9  1‏
919 ‎‡a  lossoftheephreceptorb6contributestocolorectalcancermetastasis‏ ‎‡A  Loss of the EPH receptor B6 contributes to colorectal cancer metastasis‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  BNCHL|10000000000000000825552‏
996 ‎‡2  BNCHL|10000000000000000857927‏
996 ‎‡2  ISNI|0000000079307179‏
996 ‎‡2  SUDOC|188107452‏
996 ‎‡2  RERO|A000111256‏
996 ‎‡2  LC|no2010097697‏
996 ‎‡2  ISNI|0000000080030824‏
996 ‎‡2  JPG|500330173‏
996 ‎‡2  DNB|136716504‏
996 ‎‡2  ISNI|0000000030582479‏
996 ‎‡2  LC|no2008060481‏
996 ‎‡2  ISNI|0000000047272629‏
996 ‎‡2  ISNI|0000000080598831‏
996 ‎‡2  ISNI|000000005017320X‏
996 ‎‡2  LC|n 88268797‏
996 ‎‡2  LC|no2010087985‏
996 ‎‡2  BNCHL|10000000000000000123758‏
996 ‎‡2  SUDOC|228253004‏
996 ‎‡2  LC|nr2001036266‏
996 ‎‡2  LC|nr2001006431‏
996 ‎‡2  ISNI|0000000050248881‏
996 ‎‡2  DNB|1165107422‏
996 ‎‡2  DNB|1157702309‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏